pharma · RSV Infection · NASH - Nonalcoholic Steatohepatitis · ENTA
ENANTA PHARMACEUTICALS
ENANTA PHARMACEUTICALS INC
ENANTA PHARMACEUTICALS clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 4 Kingsbury Ave, Watertown, Massachusetts 02472, US
- Founded
- 1995
- Employees
- 145
- Programs
- 34
- Drugs
- 15
- Patents
- 218
ENANTA PHARMACEUTICALS projects
13 ClinicalTrials.gov programs sponsored by ENANTA PHARMACEUTICALS.
ENANTA PHARMACEUTICALS has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
EDP-235
ENANTA PHARMACEUTICALS INC
COVID-19
3 trials -
EDP-305 1 mg
ENANTA PHARMACEUTICALS INC
Primary Biliary Cholangitis
1 trial -
EDP-305 1.5 mg
ENANTA PHARMACEUTICALS INC
Non-Alcoholic Steatohepatitis
1 trial -
EDP-305 Dose 1
ENANTA PHARMACEUTICALS INC
Non-Alcoholic Steatohepatitis
1 trial -
EDP-323 Dose Regimen 1
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial -
EDP-420 / Duration of Treatment - 3 days
ENANTA PHARMACEUTICALS INC
Community Acquired Pneumonia
1 trial -
EDP-938
ENANTA PHARMACEUTICALS INC
RSV Infection
6 trials -
EDP-938
ENANTA PHARMACEUTICALS INC
Respiratory Syncytial Virus
1 trial -
EDP-938
ENANTA PHARMACEUTICALS INC
Respiratory Syncytial Virus Infections
1 trial -
EDP-938
ENANTA PHARMACEUTICALS INC
Respiratory Syncytial Virus (RSV)
2 trials -
EDP-938 Dose 1
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial -
EDP-938, EDP-938 Placebo tablets
ENANTA PHARMACEUTICALS INC
Respiratory syncytial virus (RSV)
1 trial -
zelicapavir
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial
Frequently asked questions
How many clinical projects does ENANTA PHARMACEUTICALS have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.